Policy & Law NAD Reccomends Willow Health Discontinue Semiglutide ClaimsBy adminDecember 10, 20250 Key Takeaways A recent NAD decision underscores that advertising compounded drugs in a way that implies they share the benefits…
Policy & Law FTC and NAD Enforcement PrioritiesBy adminNovember 28, 20250 The Federal Trade Commission and National Advertising Division of BBB National Programs set forth their enforcement priorities during the 2025…
Policy & Law NAD Examines “Review Hijacking” Allegations in Supplement AdsBy adminOctober 26, 20250 The Federal Trade Commission filed its first “review hijacking” case in which a marketer purported repurposes reviews of another product…
